1. Megadose CD34+ Cell Grafts Improve Recovery of T Cell Engraftment but not B Cell Immunity in Patients with Severe Combined Immunodeficiency Disease Undergoing Haplocompatible Nonmyeloablative Transplantation 
Christopher C. Dvorak, Giun-Yi Hung, Biljana Horn, Elizabeth Dunn, Ching-Ying Oon, Morton J. Cowan 
Biology of Blood and Marrow Transplantation 
Volume 14, Issue 10, Pages (October 2008)
DOI: /j.bbmt
Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Kaplan-Meier overall survival and EFS estimates. The probabilities of OS and EFS for the 15 patients with SCID undergoing nonmyeloablative T cell–depleted haplocompatible megadose peripheral blood stem cell transplantation with a fixed dose of CD3+ cells.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2008 American Society for Blood and Marrow Transplantation Terms and Conditions